[1] 张清慧,李萌,孔园园等.2006-2015年上海市松江区乙型病毒性肝炎流行状况及防控效果评价.实用预防医学,2017,24:716-719.
[2] 武荣,杜秀芳,王坤等.临汾市尧都区2010～2015年病毒性肝炎流行病学特征分析.中国老年学杂志,2017,37:5446-5448.
[3] Cheng L S,Liu Y,Jiang W. Restoring homeostasis ofCD4( + )T cells in hepatitis-B-virus-related liver fibrosis. World J Gastroenterol,2015,21:10721-10731.
[4] Collison L W,Delgoffe G M,Guy c S, et al. The composition and signaling of the IL-35 receptor are un-conventional. Nat Immunol,2012,13:290-299.
[5] Collison L W,Chaturvedi V,Henderson A L,et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol,2010,11:1093-1101.
[6] 黄昌胜,沈关心. IL-35 在机体对HBV 感染免疫应答中的调节作用. 医学分子生物学杂志, 2017, 14:246-248.
[7] 李建军.探讨补肾益气疏肝凉血活血方对乙肝肝纤维化患者的疗效及免疫功能的影响.中医临床研究,2017,9:70-71.
[8] Yun L,Li s C,Sheng D W,et al. IL-10 producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chron HBV infection. Clin Sci,2016,130:907-919.
[9] Guo Y,He Y,zhaIlg Y,et al. Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-ChronicHepatitis B Liver Failure: A case-control study.Medicine, 2015,94:e1501.
[10] 张洁,周振华,孙学华等.单核巨噬细胞与乙型肝炎病毒感染的研究进展.中西医结合肝病杂志,2017,27:185-189.
[11] 王玉泽,张海丛,叶立红,等.乙肝病毒对脂肪肝患者肝功能及血清肿瘤坏死因子-α与白细胞介素-6的影响.现代中西医结合杂志,2016,25:612-614.
[12] 李孝楼,卓海燕,刘志强,等核苷和核苷酸类药物治疗慢性乙型肝炎停药后复发并进展为肝衰竭患者的临床特征及预后影响因素分析.临床肝胆病杂志,2018,34:1423-1427. |
